Funding
- Deutsche Forschungsgemeinschaft, SFB643, „Strategies of cellular immune intervention“, Teilprojekt A1
- ViroLogik GmbH, IZMP (Innovationszentrum für Medizintechnik und Pharma), Erlangen
- MetrioPharm AG, Zurich, Switzerland
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF), „Inflammatory Processes: Ethiopathogenesis, Diagnostics and Therapy“, Teilprojekt A70
- ImmunoLogik GmbH, Berlin
Collaborations
- Prof. Dr. Sylvie Le Gall, Ragon Institute, USA
- Prof. Dr. Gerhard Thiel, Technical University of Darmstadt, Germany
- Dr. Ashok Balasubramanyam, Baylor College of Medicine, Houston, TX, USA
- Prof. Dr. Torgils Fossen, Department of Chemistry, University of Bergen, Norway
- Dr. Petra Henklein, Humboldt University, Berlin, Germany
- Dr. Norbert Bannert, Robert Koch-Institute, Berlin, Germany
- Prof. Dr. Michael Schindler, Medizinische Virologie und Epidemiologie der Viruskrankheiten, Universitätsklinikum Tübingen, Germany
- Prof. Dr. Frank Kirchhoff, University of Ulm, Germany
- Dr. Niels Schaft and Dr. Jan Dörrie, Department of Dermatology, University of Erlangen-Nürnberg, Germany
- Prof. Dr. Eric O. Freed, National Cancer Institute (at National Institutes of Health), Frederick, USA
- Prof. Dr. Carol Carter, Molecular Genetics & Microbiology, Stony Brook University, Stony Brook (NY), USA
- Prof. Dr. Diana Dudziak, Department of Dermatology, University of Erlangen-Nürnberg, Germany
- Dr. Harald Wodrich, Laboratoire de Microbiologie Fondamentale et Pathogénicité, Bordeaux, France
- Dr. Vladimir Temchura / Prof. Dr. Klaus Überla, Institute of Virology, University of Erlangen-Nürnberg, Germany
- Dr. Maximilian Traxdorf, Department of Otorhinolaryngology, Head and Neck Surgery, University of Erlangen-Nürnberg, Germany